Surgical and Transcatheter Mitral Valve Therapy: Medicare Utilization and Reimbursement

Medicare utilization of mitral valve therapies has been stable in recent years, with growth of transcatheter volumes offset by a decrease in surgical volumes. This suggests that transcatheter therapy availability has not expanded the pool of patients with access to therapy. Nonetheless, case reimbursements decreased among both modalities.